If a contract manufacturer (CMO) makes your product, you may think compliance is their problem. It isn't. The FDA holds the brand owner accountable—and the documentation gap between you and your CMO is exactly where warning letters are born.
Under 21 CFR Part 111 (dietary supplements) and applicable Good Manufacturing Practice regulations, GMP compliance obligations follow whoever sells the product—not whoever manufactures it. If your label says "Distributed by" or "Manufactured for," you are the responsible party in the FDA's eyes.
This matters because most brand owners who use contract manufacturers have little to no documented oversight of that relationship. They sign a purchase order, review a COA, and ship product. The FDA looks for something very different: a documented quality system that shows the brand owner actively oversees the manufacturing process, even when they're not on the factory floor.
⚠️ Your CMO's cGMP certification does not cover your brand. Their registration satisfies their obligations. Yours require separate documentation—quality agreements, supplier qualifications, and internal SOPs you actually own.
Most brand owners fail on the same four fronts when the FDA comes knocking. These aren't obscure technicalities—they're the first things an investigator checks. Enter your name and email to get the full guide.
Enter your name and email. We'll send the guide to your inbox and unlock it here immediately. No spam—just the guide and occasional GMP compliance resources.
Most brand owners fail on the same four fronts when the FDA comes knocking. These aren't obscure technicalities—they're the first things an investigator checks.
A written contract defining who is responsible for what between you and your CMO. Without one, FDA investigators assume you have no control over the manufacturing process. See the full checklist →
Documentation showing you vetted your CMO before engaging them. FDA expects evidence of qualification—not just a business relationship.
Procedures showing you review and approve finished product before releasing it for sale. Brand owners who outsource are still expected to perform this oversight.
Standard Operating Procedures scoped to your brand: incident management, label review, adverse event reporting. Your CMO's SOPs don't cover your operations.
When an FDA investigator finds a GMP violation, they cite the company whose name appears on the product label—not the contract manufacturer. If your CMO has documentation problems, you inherit the enforcement action. Brand owners have received Warning Letters for violations that happened at facilities they never operated and sometimes never visited.
The consequences go beyond legal exposure. Warning Letters are public. They show up in procurement databases, retailer compliance checks, and investor due diligence. A single Warning Letter can cost more in lost revenue than the documentation would have cost to build correctly.
The FDA's position on the use of contract manufacturing organizations (CMOs), as reflected in multiple warning letters, is clear: while companies may outsource manufacturing, packaging, and labeling activities, they cannot outsource or abdicate their ultimate legal responsibility for product quality and compliance.
Ultimate Responsibility Remains with the Brand Owner
Companies that distribute products under their own name—regardless of whether they use a contract manufacturer—are fully responsible for ensuring their products comply with all relevant Good Manufacturing Practice (GMP) requirements.
The FDA states repeatedly that outsourcing operations does not transfer or negate the obligation to ensure products are not adulterated and that all cGMP standards are met.
GMP Playbook is a flat-rate documentation service built specifically for brand owners. We don't sell consulting hours or retainers. We deliver a complete, customized GMP documentation package in 4 weeks—everything you need to demonstrate compliance oversight of your CMO relationship.
A CMO-ready quality agreement that defines responsibilities, documentation ownership, and oversight procedures. Accepted by most co-manufacturers without negotiation.
Questionnaires, audit checklists, and approval records that document your due diligence in selecting and onboarding your manufacturing partner.
A documented procedure for how your team reviews and approves each finished product before it ships—showing the FDA you have active quality oversight.
Incident management, label control, adverse event reporting, and product release. Editable Word documents, scoped to outsourced manufacturing models.
Product specifications and a label review checklist that demonstrate your compliance with labeling requirements before any product reaches shelves.
✓ From zero documentation to audit-ready in 4 weeks. Flat rate. No hourly billing, no retainer, no consultants billing by the hour to explain regulations.
Two tiers based on SKU count. No surprises.
Tell us about your brand and we'll confirm which package fits. No sales pressure—just a straightforward conversation about what you need to be audit-ready.